PROCEPT BioRobotics Corporation
NASDAQ: PRCT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Larry L. Wood
- Employees
- 756
- Headquarters
- San Jose, United States
- IPO year
- 2021
- Market cap
- $1.2B
- Website
- https://www.procept-biorobotics.com
Loading PRCT…
Loading profile data…Frequently asked questions about PRCT
What does PROCEPT BioRobotics Corporation (PRCT) do?
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation...
Where does PRCT trade?
PROCEPT BioRobotics Corporation (PRCT) trades on the NASDAQ Global Market.
What sector is PRCT in?
PROCEPT BioRobotics Corporation (PRCT) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of PROCEPT BioRobotics Corporation?
Larry L. Wood is the chief executive officer of PROCEPT BioRobotics Corporation (PRCT).
Where is PROCEPT BioRobotics Corporation headquartered?
PROCEPT BioRobotics Corporation is headquartered in United States.
Does PRCT pay a dividend?
PROCEPT BioRobotics Corporation (PRCT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PRCT go public?
PROCEPT BioRobotics Corporation (PRCT) completed its initial public offering in 2021.